tiprankstipranks
Trending News
More News >
Orchestra Biomed Holdings, Inc. (OBIO)
NASDAQ:OBIO
US Market

Orchestra BioMed Holdings (OBIO) Financial Statements

Compare
99 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently $238.28M. The company's EPS TTM is $-0.4; its P/E ratio is -2.32; Orchestra BioMed Holdings is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.64M$ 2.76M$ 3.53M$ -782.00K$ 5.70M
Gross Profit$ 2.43M$ 2.57M$ 3.21M$ -981.00K$ 5.56M
Operating Income$ -64.30M$ -51.51M$ -32.66M$ -21.80M$ -18.75M
EBITDA$ -63.99M$ -51.22M$ -32.44M$ -21.62M$ -18.61M
Net Income$ -61.02M$ -49.12M$ -33.61M$ -23.01M$ -21.36M
Balance Sheet
Cash & Short-Term Investments$ 66.81M$ 87.59M$ 83.78M$ 10.90M$ 35.79M
Total Assets$ 76.17M$ 95.21M$ 95.57M$ 13.53M$ 38.09M
Total Debt$ 16.53M$ 1.69M$ 11.87M$ 5.67M$ 9.46M
Net Debt$ -5.73M$ -28.87M$ -7.91M$ -4.26M$ -10.89M
Total Liabilities$ 43.22M$ 27.17M$ 43.04M$ 84.76M$ 86.63M
Stockholders' Equity$ 32.96M$ 68.04M$ 52.53M$ -71.23M$ -48.54M
Cash Flow
Free Cash Flow$ -50.85M$ -46.20M$ -29.88M$ -19.70M$ -26.72M
Operating Cash Flow$ -50.56M$ -46.13M$ -29.29M$ -19.43M$ -26.18M
Investing Cash Flow$ 13.09M$ 10.69M$ -64.12M$ 13.02M$ 26.97M
Financing Cash Flow$ 29.17M$ 46.22M$ 103.26M$ -3.99M$ 10.00M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Orchestra BioMed Holdings Debt to Assets

Orchestra BioMed Holdings Cash Flow

Orchestra BioMed Holdings Forecast EPS vs Actual EPS